70 related articles for article (PubMed ID: 38731979)
1. Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies.
Duan F; Wang K; Dai L; Zhao X; Feng Y; Song C; Cui S; Wang C
Medicine (Baltimore); 2016 Sep; 95(37):e4773. PubMed ID: 27631228
[TBL] [Abstract][Full Text] [Related]
2. The Importance of HHLA2 in Solid Tumors-A Review of the Literature.
Kula A; Koszewska D; Kot A; Dawidowicz M; Mielcarska S; Waniczek D; Świętochowska E
Cells; 2024 May; 13(10):. PubMed ID: 38786018
[TBL] [Abstract][Full Text] [Related]
3. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of HHLA2 in Patients with Solid Tumors: A Meta-Analysis.
Kula A; Dawidowicz M; Mielcarska S; Świętochowska E; Waniczek D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731979
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population.
Zhang C; Xu J; Ye J; Zhang X
Medicine (Baltimore); 2021 Jul; 100(30):e26789. PubMed ID: 34397730
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
Zhao X; Lu H; Sun Y; Liu L; Wang H
Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-Analysis.
Dawidowicz M; Kula A; Mielcarska S; Świętochowska E; Waniczek D
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732263
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
[TBL] [Abstract][Full Text] [Related]
10. Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma.
Nishihara D; Kijima T; Arai K; Kamai T
Int Urol Nephrol; 2023 Apr; 55(4):867-874. PubMed ID: 36598731
[TBL] [Abstract][Full Text] [Related]
11. Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer.
Lv C; Han S; Wu B; Liang Z; Li Y; Zhang Y; Lang Q; Zhong C; Fu L; Yu Y; Xu F; Tian Y
Front Immunol; 2022; 13():984172. PubMed ID: 36159808
[TBL] [Abstract][Full Text] [Related]
12. HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
Huang FX; Wu JW; Cheng XQ; Wang JH; Wen XZ; Li JJ; Zhang Q; Jiang H; Ding QY; Zhu XF; Zhang XS; Ding Y; Li DD
Front Immunol; 2022; 13():902167. PubMed ID: 36003385
[TBL] [Abstract][Full Text] [Related]
13. KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
Li Y; Lv C; Yu Y; Wu B; Zhang Y; Lang Q; Liang Z; Zhong C; Shi Y; Han S; Xu F; Tian Y
J Adv Res; 2023 May; 47():137-150. PubMed ID: 35933091
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]